AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 263: E663-E666, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, A.
Right arrow Articles by Efendic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, A.
Right arrow Articles by Efendic, S.

AJP - Endocrinology and Metabolism, Vol 263, Issue 4 E663-E666, Copyright © 1992 by American Physiological Society


ARTICLES

Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice

A. Khan, C. G. Ostenson, P. O. Berggren and S. Efendic
Rolf Luft Center for Diabetes Research, Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.

Normoglycemic ob/ob mice were treated for 24 or 48 h with either 25 micrograms/day of dexamethasone or saline. After an overnight fast, the animals were killed and pancreatic islets were incubated with 3H2O or [U-14C]glucose or [5-3H]glucose at 5.5 and 16.7 mM glucose. Incorporation of 3H from 3H2O into carbon 2 of medium glucose and the yield of 14CO2 from [U-14C]glucose and 3H2O from [5-3H]glucose were measured. Dexamethasone treatment for 48 h significantly increased the rate of dephosphorylation of glucose in islets both at 5.5 mM (24 vs. 16%) and 16.7 mM (56 vs. 36%) glucose, whereas glucose oxidation and utilization were unaffected. Dexamethasone treatment also inhibited insulin release by approximately 60% at 5.5 and 16.7 mM glucose, either in the presence or absence of 10 mM arginine, but had no effect when insulin release was stimulated by 1 mM 3-isobutyl-1-methylxanthine. Moreover, 24-h treatment with dexamethasone significantly increased glucose cycling at low and high glucose concentrations in the medium and inhibited insulin responsiveness to glucose and arginine. In conclusion, short-term dexamethasone treatment increases glucose flux through glucose-6-phosphatase in islets from ob/ob mice. This effect may contribute to the decreased insulin response to glucose and arginine found in animals treated with dexamethasone.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Gremlich, R. Roduit, and B. Thorens
Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic beta Cells. COMPARISON WITH THE EFFECTS OF FATTY ACIDS
J. Biol. Chem., February 7, 1997; 272(6): 3216 - 3222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Davani, A. Khan, M. Hult, E. Martensson, S. Okret, S. Efendic, H. Jornvall, and U. C. T. Oppermann
Type 1 11beta -Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets
J. Biol. Chem., November 3, 2000; 275(45): 34841 - 34844.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online